LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock financials
$23.15−0.22%
Close Sep 25, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $47.3M | $50.2M | $7.1M | $60.2M | $49.0M | $50.9M | $5.5M | $53.3M | $50.7M | $44.1M | $44.9M | $38.6M |
| Gross profit | $42.0M | $44.2M | $2.8M | $52.8M | $42.2M | $42.8M | -$1.3M | $48.3M | $45.6M | $39.5M | $39.5M | $33.8M |
| Gross margin | 88.8% | 88.2% | 40.2% | 87.7% | 86.0% | 84.0% | −24.0% | 90.6% | 90.1% | 89.6% | 88.1% | 87.6% |
| Operating income | -$7.1M | -$8.9M | -$6.2M | -$2.0M | -$2.3M | -$1.2M | -$6.0M | -$4.0M | -$6.3M | -$6.2M | -$2.2M | -$4.6M |
| Net income | -$7.9M | -$9.6M | $19.2M | -$4.6M | -$2.4M | -$960.3K | -$5.7M | -$5.4M | -$7.7M | -$7.5M | -$4.5M | -$6.9M |
| Net margin | −16.6% | −19.2% | 271.0% | −7.6% | −4.9% | −1.9% | −104.2% | −10.2% | −15.1% | −17.1% | −10.1% | −17.9% |
| Diluted EPS | $-0.16 | $-0.20 | $0.41 | $-0.10 | $-0.05 | $-0.02 | $-0.14 | $-0.13 | $-0.19 | $-0.19 | $-0.12 | $-0.20 |
| EBITDA | -$5.1M | -$6.9M | -$7.4M | $1.0M | -$561.5K | $509.7K | -$6.7M | -$1.4M | -$4.0M | -$4.1M | -$230.8K | -$2.8M |
| Operating cash flow | -$6.9M | $444.6K | -$3.3M | -$147.1K | $8.6M | $3.1M | $1.1M | $6.7M | $4.5M | $5.2M | $5.7M | $1.1M |
| Free cash flow | -$7.0M | $339.4K | -$3.4M | -$944.4K | $7.9M | $3.0M | $875.4K | $6.3M | $3.9M | $5.0M | $5.6M | $1.0M |
| Diluted shares | 47.8M | 47.3M | 46.8M | 46.2M | 44.4M | 43.1M | 42.2M | 42.0M | 41.3M | 39.2M | 36.9M | 34.5M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $25.1M | $34.5M | $36.8M | $23.8M | $36.2M | $34.4M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $15.5M | $18.4M |
| Total assets | $59.9M | $70.1M | $70.4M | $66.0M | $73.6M | $73.6M |
| Total liabilities | $51.9M | $55.1M | $47.3M | $62.6M | $73.2M | $74.0M |
| Shareholders' equity | $8.0M | $15.0M | $23.2M | $3.4M | $382.4K | -$392.8K |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology